Suberoylanilide Hydroxamic Acid in Treating Patients With Progressive Stage IV Breast Cancer
Status:
Terminated
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well suberoylanilide hydroxamic acid works in treating
patients with progressive stage IV breast cancer. Drugs used in chemotherapy, such as
suberoylanilide hydroxamic acid, work in different ways to stop the growth of tumor cells,
either by killing the cells or by stopping them from dividing. Suberoylanilide hydroxamic
acid may also stop the growth of tumor cells by blocking some of the enzymes needed for cell
growth